Fujifilm submits digital mammo for FDA clearance

Fujifilm Medical Systems has submitted its new Aspire HD full-field digital mammography (FFDM) system application to the FDA for 510(k) marketing clearance.

The Aspire HD FFDM system has 50 um pixel resolution, along with Image Intelligence, Fujifilm’s proprietary image processing technology, according to the Stamford, Conn.-based company. Additionally, Aspire HD has a proprietary detector that uses a dual layer amorphous selenium design, coupled with Fujifilm’s Direct Optical Switching (DOS) technology.

The Aspire HD FFDM system requires FDA 510(k) clearance and is not yet available for sale in the U.S.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.